cognitive disorders Flashcards
1
Q
delirium: general
A
- waxing-and-waning change in level of consciousness
- caused by almost any medical d/o
- high morbidity and mortality if untreated
2
Q
delirium: epidem
A
- 10-30% of admitted medical pts
- common in elderly, ICU, postop, cancer pts
3
Q
delirium: risk factors
A
- adv age
- brain damage
- prior delirium
- alcohol dependence
- cancer
- sensory impairment, blindness
- malnutrition
- male gender
4
Q
delirium: clinical
A
MOST common: impairment in recent memory
- disorientation, usually to time/place
- language disturbances, speech changes
- perceptual disturbances, esp visual hallucinations
- sleep disturbances: SUNDOWNING (daytime drowsiness and night-time insomnia)
- disturbed psychomotor behavior
- emotional disturbances
- perseveration
5
Q
delirium: dx
A
- disturbance of consciousness w/reduced ability to focus, sustain, shift attn
- change in cognition or development of perceptual disturbance (can’t be accounted for by dementia)
- disturbance develops over short period of tie and fluctuates
6
Q
delirium: tx
A
- r/o life-threatening cause, find underlying condition
- hydration, nutrition
- 1:1, orient patient, good sleep hygiene
- Haldol for agitation
- BZOs only for DTs
7
Q
dementia: general
A
- impairment of memory and other cognitive fns WITHOUT altered consciousness
- most forms progressive, irreversible
- prevalence doubles every 5 years: 1.5% at 60 yrs, 40% at 90 yrs
- Alzheimer’s most common, vascular dementia 2nd
8
Q
dementia: dx
A
- multiple cognitive deficits manifested by BOTH: memory impairment and 1+ of: aphasia, apraxia, agnosia, decreased executive fn
- cognitive deficits must cause significant impairment and are significant decline
- do not occur only during delirium
9
Q
dementia: assoc sx
A
- delusions and hallucinations: 30%
- affective sx: 40-50%
- personality changes
10
Q
dementia: reversible causes
A
- workup CBC, electrolytes, TFTs, VDRL/RPR, B12/folate, brain CT/MRI
- hypothyroidism
11
Q
Alzheimer: epidem
A
- most common type of dementia
- women 3x > men
- 1st degree relative –> 4x risk
- Down syndrome –> increased risk
12
Q
Alzheimer: clinical
A
- gradual progressive decline in cognitive fn
- personality chg, mood swings, paranoia common
- motor and sensory sx absent until late in cours
13
Q
Alzheimer: dx
A
- clinical, dx of exclusion unless post-mortem
- genes: only 5% of cases; APOe4 gene –> homozygotes have 50-90% chance, heterozygotes 45% chance
- 20% chance overall
- postmortem: diffuse atrophy with enlarged ventricles, flattened sulci
- senile plaques and NF tangles
14
Q
Alzheimer: pathophys
A
- decrease in ACh - loss of noradrenergic neurons in basal ceruleus and decreased choline acetyltransferase
- excess of Abeta peptides (overprod, decreased clearance)
15
Q
Alzheimer: tx
A
- cholinesterase inhibs for mild-mod dz
- tacrine, donepezil, rivastigmine, galantamine
- NMDA antagonists for mod-severe dz
- memantine